SLC1A3 and neoplasm: Although asparagine availability can be maintained through both de novo synthesis via ASNS and uptake via SLC family transporters (e.g., SLC1A3, SLC1A5), transporter-mediated compensation is incomplete in rapidly proliferating solid tumors, particularly under the nutrient-limited conditions of the tumor microenvironment [49,50,51].